As of 2024-12-12, the Intrinsic Value of AstraZeneca PLC (AZN.L) is
5,577.87 GBP. This AZN.L valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 10,538.00 GBP, the upside of AstraZeneca PLC is
-47.10%.
The range of the Intrinsic Value is 3,534.80 - 11,104.79 GBP
10,538.00 GBP
Stock Price
5,577.87 GBP
Intrinsic Value
AZN.L Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
a |
DCF (Growth 5y) |
3,534.80 - 11,104.79 |
5,577.87 |
-47.1% |
DCF (Growth 10y) |
4,643.58 - 13,247.52 |
6,988.08 |
-33.7% |
DCF (EBITDA 5y) |
5,609.65 - 8,328.29 |
7,540.25 |
-28.4% |
DCF (EBITDA 10y) |
6,383.40 - 10,214.51 |
8,713.10 |
-17.3% |
Fair Value |
8,177.81 - 8,177.81 |
8,177.81 |
-22.40% |
P/E |
5,574.03 - 8,715.84 |
7,273.23 |
-31.0% |
EV/EBITDA |
6,235.48 - 9,026.02 |
7,743.35 |
-26.5% |
EPV |
3,540.57 - 5,488.41 |
4,514.49 |
-57.2% |
DDM - Stable |
2,470.74 - 7,959.85 |
5,215.30 |
-50.5% |
DDM - Multi |
3,884.22 - 9,134.17 |
5,386.68 |
-48.9% |
AZN.L Intrinsic Value - Key Valuation Metrics
Market Cap (mil) |
162,818.42 |
Beta |
1.32 |
Outstanding shares (mil) |
15.45 |
Enterprise Value (mil) |
183,707.44 |
Market risk premium |
5.98% |
Cost of Equity |
10.48% |
Cost of Debt |
4.46% |
WACC |
9.64% |